Sofpironium bromide indirectly reduces the rate of sweating by preventing the stimulation of acetylcholine receptors that are located on sweat glands. The Food and Drug Administration (FDA) has ...

Branded content. Us Weekly has affiliate partnerships so we may receive compensation for some links to products and services. Our bodies are incredible organisms, constantly at work to maintain a ...

Please provide your email address to receive an email when new articles are posted on . Sofdra (sofpironium) gel 12.45% is the first and only chemical entity for primary axillary hyperhidrosis. The ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved ...

Treatment of hyperhidrosis can be divided into topical, oral, surgical, and nonsurgical treatments (botulinum toxin). These therapeutic options differ with respect to their efficacy, duration of ...

Please provide your email address to receive an email when new articles are posted on . Treatment with sofpironium bromide gel reduced the severity of primary axillary hyperhidrosis in a cohort of ...

Hyperhidrosis most commonly affects the armpits, followed by the palms of the hands and the soles of the feet. Impairment of quality of life differs based on where primary hyperhidrosis manifests on ...

Discusses Quarterly Activity, Cash Flow Update, and Progress of Sofdra for Hyperhidrosis January 26, 2026 7:30 ...

Sofpironium bromide is a structural analogue of glycopyrrolate, an anticholinergic agent. Positive topline results were announced from 2 identical phase 3 studies evaluating sofpironium bromide in ...

Hyperhidrosis is defined as excessive eccrine sweating that is quantitatively greater than that required for normal thermoregulation. It is a common problem seen by endocrinologists. At the 40th ...

Colorado-based Brickell, which focuses on developing therapeutics for the treatment of debilitating skin diseases, announced publication in the Journal of the American Academy of Dermatology positive ...